S&P 500 7,676.77 +0.70%
Nasdaq 26,169.38 +0.82%
S&P/TSX 35,944.16 +0.44%
Apple 343.91 −1.10%
Nvidia 216.00 +2.39%
Microsoft 532.60 +1.54%
Shopify 235.93 −0.13%
Royal Bank 284.26 +0.88%
CAD/USD 0.7132 −0.06%
CLOSED · 03:50 ET
Market ClerkRecap
Tue Oct 27 · markets closed1 signal on Oct 26140 insider buys this week · $73.9MCIRO short report next: Oct 30The week ahead

ELVN

Enliven Therapeutics, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
41.49
−0.03 −0.07%
USD · Oct 26, 07:41 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $3BP/E —DIV YIELD —FCF YIELD -2.21%REV TTM —NET INCOME −$105.9MNET CASH —52W 15.14 – 61.15NEXT EARNINGS Nov 11 EST.SEC XBRL · TTM TO Invalid Date

What ELVN had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Oct 14Officer or director changeReg FD disclosureOct 14open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch ELVN. Know when insiders buy.
One email the day a filing lands. Free.